Discovery of novel dual STAT3/TrxR1 inhibitors via pharmacophore fusion as potent lead compounds for colorectal cancer. // Bioorganic & Medicinal Chemistry Letters. – URL: https://www.sciencedirect.com/science/article/pii/S0960894X26002441?dgcid=rss_sd_all
Discovery of novel dual STAT3/TrxR1 inhibitors via pharmacophore fusion as potent lead compounds for colorectal cancer. Bioorganic & Medicinal Chemistry Letters. https://www.sciencedirect.com/science/article/pii/S0960894X26002441?dgcid=rss_sd_all
“Discovery of novel dual STAT3/TrxR1 inhibitors via pharmacophore fusion as potent lead compounds for colorectal cancer.” Bioorganic & Medicinal Chemistry Letters.
@article{article73236,
title = {Discovery of novel dual STAT3/TrxR1 inhibitors via pharmacophore fusion as potent lead compounds for colorectal cancer},
journal = {Bioorganic \& Medicinal Chemistry Letters},
url = {https://www.sciencedirect.com/science/article/pii/S0960894X26002441?dgcid=rss_sd_all}
}
ABSTRACT Singlet oxygen ( 1 O 2 ) is increasingly recognized as a key reactive species in advanced oxidation processes (AOPs) due to its long lifetime, wide pH tolerance, and selective oxidation behaviours toward electron‑rich organic...
ABSTRACT The Truce–Smiles rearrangement (TSR) is a versatile synthetic strategy for carbon–carbon bond formation without the need of metal catalysis. The key step is formation of spiro‐Meisenheimer complex which typically undergoes the...